Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-07

Clinical Trial Update: The Efficacy and Safety of Levetiracetam Versus Fosphenytoin in Convulsive Status Epilepticus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing levetiracetam versus fosphenytoin for convulsive status epilepticus, currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)
  • fosphenytoin (fosphenytoin)

Snippet

Sponsor: Dhaka Medical College | Conditions: Status Epilepticus | Phase 4 | Status: ENROLLING_BY_INVITATION